iNtuition-Structural Heart Module vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

iNtuition-Structural Heart Module

by TeraRecon

EchoNext

by Pathway Labs

AI Verdict

These tools are adjacent in their focus on structural heart disease but serve different stages of the patient journey. TeraRecon's iNtuition-Structural Heart Module is designed for advanced visualization and precise measurements for pre- and post-operative planning using imaging data. In contrast, Pathway Labs' EchoNext is an AI-powered screening tool that analyzes standard ECGs to detect hidden structural heart disease, identifying patients who may need further evaluation.

Choose iNtuition-Structural Heart Module if…

Choose iNtuition-Structural Heart Module if your cardiology or cardiothoracic surgery practice requires advanced 2D/3D/4D visualization and precise measurements for complex pre-operative planning, sizing, and post-operative evaluation of structural heart interventions. This tool is ideal for detailed segmentation of cardiovascular structures and specialized workflows like Transcatheter Mitral Valve Repair (TMVR) and Left Atrial Appendage (LAA) procedures.

View iNtuition-Structural Heart Module →

Choose EchoNext if…

Choose EchoNext if your practice needs a non-invasive, AI-powered solution to screen for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. This tool is particularly well-suited for broad access in various clinical settings, from major hospitals to community practices, to identify at-risk patients early in the diagnostic pathway.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	iNtuition-Structural Heart Module	EchoNext
Pricing	Subscription-based	Starts at $600/month
Deployment	Software as a Medical Device (SaMD), available as a stand-alone workstation or a server. Access via local user, thin client application, or zero-footprint web viewer. Also offered as a SaaS-based solution.	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iNtuition-Structural Heart Module

Tool A (iNtuition-Structural Heart Module) offers flexible deployment options including stand-alone workstation, thin client, zero-footprint web viewer, and SaaS, suggesting a versatile and accessible user experience. Its focus on advanced visualization and automated workflows for complex procedures also points to a design aimed at streamlining clinician interaction. Tool B (EchoNext) is available through a clinical decision support platform, which implies integration, but less is specified about its direct user interface or customization options.

Clinical Value

EchoNext

Tool B (EchoNext) demonstrates significant clinical value by detecting hidden structural heart disease from standard ECGs with higher accuracy than cardiologists, even those with AI assistance. This capability addresses a critical gap in early detection for cardiovascular disease, the leading cause of death globally. Tool A (iNtuition-Structural Heart Module) provides advanced visualization and measurements for pre- and post-operative planning, which is valuable for existing diagnoses but not focused on early, hidden disease detection.

Pricing & Value

Tie

Tool A (iNtuition-Structural Heart Module) uses a subscription-based model with flexible payment options and a 3-year price lock guarantee, offering predictability. Tool B (EchoNext) also uses tiered pricing starting at $600/month with an annual discount and add-ons. Without specific pricing tiers for Tool A or a detailed breakdown of features per tier for both, a direct comparison of overall value is difficult.

Enterprise Readiness

iNtuition-Structural Heart Module

Tool A (iNtuition-Structural Heart Module) is offered by TeraRecon, a company with a strong presence in advanced visualization, trusted by over 2,000 hospitals worldwide. Its deployment options (stand-alone, server, SaaS) and ability to integrate third-party AI algorithms via the Eureka Clinical AI platform suggest robust enterprise capabilities and scalability. Tool B (EchoNext) is available through the OpenEvidence platform, which serves a large number of US clinicians, indicating good distribution, but less is known about its direct enterprise-level deployment and integration flexibility beyond this platform.

Innovation

EchoNext

Tool B (EchoNext) represents a significant innovation as the first FDA-cleared AI tool to detect multiple hidden structural heart diseases from a standard ECG, a capability previously unavailable. This addresses a major unmet need for early detection of cardiovascular disease. While Tool A (iNtuition-Structural Heart Module) offers advanced visualization and automated workflows, its innovations are more incremental improvements within established imaging analysis paradigms.

Support & Docs

Tie

Both tools are FDA-cleared, implying a certain level of documentation and regulatory support. Tool A (iNtuition-Structural Heart Module) has a user guide available online, detailing its features and intended use. Tool B (EchoNext) is integrated with the OpenEvidence platform, which likely provides support and documentation for its users. However, specific details on the breadth and depth of support and documentation for either tool are not extensively provided in the given information, leading to a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	iNtuition-Structural Heart Module	EchoNext
Name	iNtuition-Structural Heart Module	EchoNext
Company	TeraRecon	Pathway Labs
Description	AI-powered software for cardiologists and radiologists, offering advanced visualization and precise measurements for structural heart pre-operative planning, sizing, and post-operative evaluation.	FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Key Functionality	Automatic and manual centerline detection, segmentation of cardiovascular structures, measurement tools, calcium quantification and scoring, 2D/3D/4D visualization, capture and report functionality, Left Atrial Appendage (LAA) workflow, Transcatheter Mitral Valve Repair (TMVR) workflow.	AI-powered ECG analysis, detection of hidden structural heart disease, identifies heart failure risk, screens for valve disease, detects pulmonary hypertension indicators, utilizes standard 12-lead ECGs, non-invasive diagnostic support.

Videos

Demos, reviews, and walkthroughs featuring iNtuition-Structural Heart Module and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

iNtuition-Structural Heart Module is designed to integrate with existing EMR and PACS systems, offering a unified advanced visualization workflow and faster access to image data and reporting tools. EchoNext, on the other hand, is available through the OpenEvidence clinical decision support platform, aiming to embed its screening output directly into tools physicians already use during patient visits, thereby avoiding separate workflows.

What is the accuracy and sensitivity of each tool in detecting structural heart disease?

EchoNext has demonstrated high accuracy, achieving an AUROC of 85.2% in internal tests and 78-80% in external validation for detecting structural heart disease. In head-to-head comparisons, EchoNext alone achieved 77% accuracy, outperforming cardiologists who achieved 64% accuracy, and even when cardiologists were assisted by AI, their accuracy increased modestly to 69%. iNtuition-Structural Heart Module assists cardiologists and radiologists with visualization and precise measurements for pre-operative planning, sizing, and post-operative evaluation, with derived value results having approximately 3% uncertainty depending on data noise, image acquisition, and human intervention.

Which specialties are these tools best suited for, and what specific clinical problems do they address?

iNtuition-Structural Heart Module is primarily for cardiologists, radiologists, and cardiothoracic surgeons, assisting with advanced visualization and precise measurements for structural heart pre-operative planning, sizing, and post-operative evaluation, including LAA and TMVR workflows. EchoNext is designed for a broader range of specialties including cardiology, family medicine, hospital medicine, and internal medicine, focusing on analyzing standard ECGs to detect hidden structural heart diseases like heart failure, valve disease, and pulmonary hypertension, which are often underdiagnosed.

What is the learning curve for physicians, and what kind of support is available?

TeraRecon's Intuition platform, which includes the Structural Heart Module, is designed with clinician-centric workflows and customizable templates to ensure ease of use and high adoption rates. TeraRecon also offers technical support, training, and user manuals. For EchoNext, while specific details on learning curve are not provided, its integration into the OpenEvidence platform suggests an aim for seamless adoption within existing physician tools. Pathway Labs is focused on getting EchoNext into real workflows across health systems at a national scale.

Are there audit-trail features available to track usage and AI-driven insights?

iNtuition-Structural Heart Module, as part of the iNtuition platform, supports tracking historical information about analyzed studies and the creation, transmission, and storage of reports in digital form. The platform also allows for the display of AI results within Intuition and integration with Eureka AI to trigger AI on a study and view results. The provided information does not explicitly detail audit-trail features for EchoNext, though its role in clinical decision support would likely require such capabilities.

How do these tools support multi-site rollouts and standardization of care?

TeraRecon's iNtuition solution is designed for enterprise scalability and interoperability, allowing for unified advanced visualization workflows across multiple locations and integration with existing EMR and PACS systems. It also offers standardized cardiac imaging workflows to improve efficiency and consistency. EchoNext has demonstrated consistent performance across diverse patient demographics, clinical contexts, and numerous hospitals, with validation across multiple health systems, suggesting its suitability for multi-site deployment and standardization of screening.